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Background. Measurement of serum cobalamin (Cbl) levels is the standard investigation for assessing vitamin B12 deﬁciency.
Falsely increased values of Cbl can be caused by alcoholic liver disease. Measurement of total vitamin B12 serum levels might be
misleading in alcoholics, because a tissue metabolic deﬁciency is possible even with normal serum Cbl levels. Holotranscobalamin
(HoloTC), the Cbl metabolically active fraction, is considered as a better index of vitamin B12 deﬁciency. Methods. For assessing
vitamin B12 status, we evaluated 22 adult alcoholic male patients by measuring in parallel serum Cbl, serum folate and red
blood cell folate levels, HoloTC levels by the AxSYM assay. Results. HoloTC values were reduced in 3 alcoholics with borderline-
low Cbl values. Signiﬁcant positive correlations were found between serum Cbl and HoloTC levels, serum Cbl and gamma-
glutamyltranspeptidase(GGT).Conclusion.HoloTCmeasurement isausefuloptionforassessingvitaminB12statusinalcoholics,
particularly in the subjects with borderline Cbl values and may be considered an early marker of vitamin B12 deﬁciency.
1.Introduction
Measurement of total serum cobalamin (Cbl) is the standard
screening test for assessing vitamin B12 deﬁciency, but a
diagnostic “gold standard” for this purpose is still lacking,
especially in cases with borderline values. A vitamin B12
deﬁciency increases the concentration of total plasma homo-
cysteine(tHcy)andmethylmalonicacid(MMA),whilefolate
deﬁciency only increases the concentration of tHcy. Many
authors recognize tHcy and MMA as the most sensitive
and early indicators of vitamin B12 and folate status [1,
2]. In these studies, the two metabolic markers are more
speciﬁc than serum Cbl levels; however, this opinion is not
unanimous [3, 4]. Vitamin B12 in serum is bound to pro-
teins called transcobalamin (TC): most cobalamin is carried
onTCI,alsocalledhaptocorrin(HC),and20–30%iscarried
on TC II. The TC II-cobalamin complex is called holo-
transcobalamin (HoloTC), that is, the metabolically active
fraction. The HoloTC RIA is the ﬁrst available method for
measurement of HoloTC [5]; recently, an automated assay
for measuring HoloTC on the Abbott AxSYM analyzer has
been introduced [6]. HoloTC, or “active” B12, contains the
biologically available Cbl; several studies have shown that
HoloTC is the earliest and most speciﬁc marker of vitamin
B12 deﬁciency [7, 8]. Falsely increased Cbl values are caused
by liver diseases [9]; particularly elevated serum vitamin B12
levelswerefoundinalcoholicswithliverdisease[10,11].Ina
previous paper, we have shown that some alcohol-dependent
patients with megaloblastic anemia may respond to vitamin
B12 treatment despite normal cobalamin serum levels [12].
These ﬁndings suggest that alcohol consumption may cause
falsely normal Cbl serum levels in these patients. In order
to evaluate the vitamin B12 status, we have measured the
HoloTC levels in 22 alcohol-dependent patients and inves-
tigated the association between this parameter, serum Cbl,
and other markers of alcohol abuse.2 The Scientiﬁc World Journal
2. Patientsand Methods
Twenty actively drinking male patients with alcohol depen-
dence (DSM-IV) were evaluated. All patients had a complete
blood count, performed by a Sysmex XE-2100 automated
analyzer (Sysmex, Kobe, Japan), and routine biochemistry
(Synchron LX20 Pro, Beckman Coulter, Brea, Calif, USA).
Serum creatinine concentrations were in the normal range
in all patients, but one. In parallel were measured serum
Cbl levels (normal range: 200–1100pg/mL), serum folate
(normal range: 3.1–24ng/mL), and RBC folate levels (nor-
mal range: 342–786ng/mL) by the ADVIA Centaur chemi-
luminescence assays (Siemens Medical Solution Diagnostics,
Tarrytown, NY, USA). HoloTC levels were measured by
performing the AXSYM assay (Abbot Laboratories, Abbot
Park, Ill, USA), which is based on the microparticle enzyme
immunoassay (MEIA). We used an automated assay for
HoloTC that can be used on the Abbott AXSYM immunoas-
say analyser. This method is a 2-step sandwich microparticle
enzyme immunoassay. In the ﬁrst step, a HoloTC-speciﬁc
antibody immobilized in latex microparticles captures
HoloTC in samples of serum. In step 2, the captured HoloTC
isdetectedwithaconjugateofalkalinephosphataseandanti-
TC antibody. In details, the 4-methylumbelliferyl phosphate
is added. The conjugate labelled with alkaline phosphatase
catalyzes the removal of phosphate from the substrate, gen-
erating the ﬂuorescent 4-methylumbelliferyl. This product
is ﬁnally measured by the optical method MEIA. According
to the literature, a reference interval of 40–200pmol/L
was considered as appropriate [13, 14]. Two patients were
HCV positive, none was HbSAg positive. HoloTC was also
measured in a nonalcoholic 84-years-old patient with perni-
cious anemia (PA). The diagnosis of vitamin B12 deﬁciency
was based on the following criteria: serum Cbl levels
<200pg/mL, serum folate normal or increased levels, and
RBC folate normal or decreased levels. In patients with
low or borderline-low serum Cbl (values between 201 and
300pg/mL,grayzone),reducedHoloTClevelsconﬁrmedthe
diagnosis of vitamin B12 deﬁciency. In patients with normal
or decreased serum Cbl levels, decreased RBC folate levels,
and normal or decreased serum folate levels, a diagnosis of
isolate folate deﬁciency was made. In patients with all these
parameters decreased, a diagnosis of combined deﬁciency
was made.
2.1.StatisticalDataAnalysis. Resultsarepresentedasmedian
and range. Pearson correlation analysis and unpaired t-test
were used. A P value less than 0.05 was considered statisti-
cally signiﬁcant. The statistical procedures were performed
with SPSS statistical software v11 (SPSS Inc., Chicago, Ill,
USA).
3. Results
Age, hematologic, and metabolic characteristics of the
patients are shown in Table 1. Serum folate and RBC folate
levels was decreased in 10 and 7 patients, respectively; serum
Cbl were low in one patient (196pg/mL), borderline low in
2 patients (201pg/mL and 275pg/mL, resp.), and increased
Table 1: Alcoholic patients: sex, age, hematologic, and metabolic
characteristics; N = 22 (M 22); mean age (range): 60 years (35–82).
Normal value Range Median
Hb g/dL 12.5–16.5 6–15.3 11.7
MCV fL 80–98 74–110 98.6
Ferritin
ng/mL 33–322 48–4841 551
AST U/l <37 11–251 43
ALT U/l <40 12–305 34
GGT U/l 5–37 31–2452 120
Cbl pg/mL 200–1100 196–3768 480
Folate serum
ng/mL 3.1–24 0.3–8.5 4.1
Folate RBC
ng/mL 342–786 147–1193 400
HoloTC
pmol/L >35 21–640 96
Hb: hemoglobin; MCV: mean corpuscular volume; Ferritin: serum ferritin;
AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT:
gamma-glutamyl transpeptidase; Cbl: cobalamin; RBC: red blood cells;
HoloTC: holotranscobalamin.
Table 2: HoloTC in alcoholics with low-borderline Cbl levels.
Cbl pg/mL HoloTC pmol/L
Pz 1 196 40
Pz 2 201 21
Pz 3 275 36
HoloTC: holotranscobalamin; Cbl: cobalamin.
(>1100pg/mL) in 3 patients. Median serum Cbl levels were
in the normal range. Reduced HoloTC levels were found
in all patients with low-borderline Cbl levels (Table 2). The
patient with 275pg/mL serum Cbl levels also showed a
folate deﬁciency. In the patient with PA, both serum Cbl
and HoloTC levels were very low (63pg/mL and 3.9pmol/L,
resp.). Out of 22, 14 patients were anemic (Hb < 12.5g/dL).
Anemia was severe (Hb < 8g/dL) in 3 patients, caused by
hemorrhagic gastritis in a patient and multifactorial in the
othertwo(folatedeﬁciencyandinfectivedisease,thalassemia
andchronicrenalinsuﬃciency, resp.);intheremaining ones,
a mild anemia was linked to the alcohol abuse, associated to
a folate deﬁciency in 4 patients. A signiﬁcant positive corre-
lation was found between serum Cbl and HoloTC levels (r =
0.64, P = 0.01), serum Cbl and GGT (r = 0.49, P = 0.05);
serum Cbl and HoloTC levels were inversely, but not signif-
icantly, related with MCV. No signiﬁcant correlations were
found between serum Cbl and HoloTC with serum ferritin,
AST and ALT levels.
4. Discussion
Measurement of serum Cbl concentration, serum folate
levels, and RBC folate levels has been the cornerstone for
assessing suspected cases of these vitamins’ deﬁciency; how-
ever, there are major limitations with this approach. FalselyThe Scientiﬁc World Journal 3
increased Cbl values are caused by myeloproliferative disor-
ders, liver diseases, intestinal bacterial overgrowth, congeni-
tal TC II deﬁciency, nitrous oxide, and other particular clin-
ical and laboratory circumstances [9, 15]. Increased MMA
and tHcy together can be found with primary metabolic
defects, renal insuﬃciency, and hypovolemia, while tHcy
alone can increase in alcohol abuse, folate, and vitamin B6
deﬁciency; MMA is considered a sensitive marker of vitamin
B12 deﬁciency, but the test has a limited availability. Further-
more, in the ambulatory care setting not only Cbl, but also
MMAandtHcylevelsﬂuctuatewithtimeandneitherpredict
nor preclude the presence of Cbl-responsive hematologic or
neurologic disorders [16]. Several authors have suggested
that HoloTC is the better index of Cbl deﬁciency [7, 17]a n d
the earliest marker for vitamin B12 deﬁciency in populations
at risk [18] and in the elderly [19]. In a previous paper about
megaloblastic anemic patients, we found falsely normal
serum Cbl levels only in alcoholics [12]; out of 101 adult
patientswithmegaloblasticanemia,normalCblserumlevels,
normal serum, and RBC folate levels were found only in 3
patients, all alcohol dependent, while in another, alcoholic
borderline vitamin B12 serum levels were found. All the four
patients responded to cobalamin treatment. In this study,
we have evaluated the vitamin B12 status in 22 alcoholics
by measuring not only Cbl concentrations, serum folate and
RBC folate levels, but also HoloTC levels, with the Abbott
AxSYM assay. It has been reported that liver diseases may
cause an increase in circulating Cbl [10, 11, 20]. In our study,
median serum Cbl levels were 480pg/mL; in many reports,
serum Cbl levels were found higher in alcoholics than in the
control group but generally remain in the reference range
[21,22].Asigniﬁcantpositivecorrelationwasfoundbetween
vitamin B12 and GGT, a marker of recent alcohol abuse,
as reported by others [20, 23]. With increasing alcohol-
related hepatocellular damage, serum Cbl tends to be higher;
increased serum vitamin B12 titres correlate with disease
severity, and declining levels were found during remission
of the disease [24]. This phenomenon is likely caused
by Cbl release during hepatic cytolysis and/or a defective
storage that causes vitamin B12 to leak out of the liver into
circulation; on the other hand, a diminished concentration
of TCII and a reduced clearance of HC may be the result of
an impaired synthesizing liver capability [10–20]. Therefore,
measurementoftotalvitaminB12serumlevelsmightbemis-
leading in alcoholics, because a tissue metabolic deﬁciency
is possible even with normal serum Cbl levels. A signif-
icant positive correlation was found between serum Cbl
and HoloTC levels, as reported by others using the same
immunoenzymatic assay [13, 25]. Reduced HoloTC levels
were found in 3 alcohol-dependent patients with borderline-
low Cbl levels. The patient with clinical signs of vitamin
B12 deﬁciency (pernicious anemia) showed very low levels
of HoloTC. Therefore, HoloTC measurement was useful
to identify a suspected vitamin B12 deﬁciency in alcoholic
patients, despite borderline Cbl levels. Our data, despite
the small sample number, support the assumption that
HoloTC is an early marker for diagnosing B12 deﬁciency.
Thisisapreliminaryreport:furtherconﬁrmationneedstobe
clariﬁed with more cases. As expected, in our series, folate
deﬁciency was the most common problem (out of 22, we
foundRBCfolatelowin7patients),butalsoCbldeﬁciencyis
anonnegligiblematterinthesepatients.Ourﬁndingssuggest
that in alcoholics caution is urged in the interpretation
of these vitamin assays, particularly in the subjects with
borderline-low Cbl values. In this subset of patients, HoloTC
measurement may be a useful option for assessing vitamin
B12 status.
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